---
figid: PMC7286468__CAM4-9-3691-g004
figlink: pmc/articles/PMC7286468/figure/cam43016-fig-0004/
number: F4
caption: ADT Reduced Metabolites in Ketogenesis and Fatty Acid Metabolism. (A) The
  metabolic pathway of fatty acid, acylcarnitine and ketones in the context of cellular
  metabolisms in the cytosols and mitochondria. (B, C) ADT reduced the levels of 3‐hydroxybutryic
  acid (B), fatty acid (palmitoleic acid), and acylcarnitine (octyanoyl‐carnitine,
  palmitoyl‐carnitine) (C) without changing the levels of free carnitine. The statistical
  significance (P values) of ADT‐induced changes of indicated metabolites is indicated
pmcid: PMC7286468
papertitle: Metabolomic effects of androgen deprivation therapy treatment for prostate
  cancer.
reftext: Jen‐Tsan Chi, et al. Cancer Med. 2020 Jun;9(11):3691-3702.
pmc_ranked_result_index: '13468'
pathway_score: 0.5200108
filename: CAM4-9-3691-g004.jpg
figtitle: ADT Reduced Metabolites in Ketogenesis and Fatty Acid Metabolism
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7286468__CAM4-9-3691-g004.html
  '@type': Dataset
  description: ADT Reduced Metabolites in Ketogenesis and Fatty Acid Metabolism. (A)
    The metabolic pathway of fatty acid, acylcarnitine and ketones in the context
    of cellular metabolisms in the cytosols and mitochondria. (B, C) ADT reduced the
    levels of 3‐hydroxybutryic acid (B), fatty acid (palmitoleic acid), and acylcarnitine
    (octyanoyl‐carnitine, palmitoyl‐carnitine) (C) without changing the levels of
    free carnitine. The statistical significance (P values) of ADT‐induced changes
    of indicated metabolites is indicated
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CHPT1
  - CPT2
  - ACADVL
  - Fatty acids
  - Acyl-CoA
  - Acylcarnitine
  - Ketones
  - Acetyl-CoA
  - Fatty acid B
  - 3-Hydroxybutryic Acid
  - Pelargonic acid
  - Malonylcarnitine
  - carnitine
  - Hexanoylcarnitine
  - Heptanoylcarnitine
  - Palmitoylcarnitine
genes:
- word: CPT1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: CPT2
  symbol: CPT2
  source: hgnc_symbol
  hgnc_symbol: CPT2
  entrez: '1376'
- word: VLCAD
  symbol: VLCAD
  source: hgnc_alias_symbol
  hgnc_symbol: ACADVL
  entrez: '37'
chemicals:
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: Acyl-CoA
  source: MESH
  identifier: D000214
- word: Acylcarnitine
  source: MESH
  identifier: C116917
- word: Ketones
  source: MESH
  identifier: D007659
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Fatty acid B
  source: MESH
  identifier: D005227
- word: 3-Hydroxybutryic Acid
  source: MESH
  identifier: C039620
- word: Pelargonic acid
  source: MESH
  identifier: C008776
- word: Malonylcarnitine
  source: ''
  identifier: ''
- word: carnitine
  source: MESH
  identifier: D002331
- word: Hexanoylcarnitine
  source: MESH
  identifier: C061301
- word: Heptanoylcarnitine
  source: MESH
  identifier: C524571
- word: Palmitoylcarnitine
  source: MESH
  identifier: D010172
diseases: []
figid_alias: PMC7286468__F4
redirect_from: /figures/PMC7286468__F4
figtype: Figure
---
